NewAmsterdam Pharma Company N.V. (NAMS)
NGM – Real Time Price. Currency in USD
27.83
+0.21 (0.76%)
At close: Aug 12, 2026, 4:00 PM EDT
27.83
0.00 (0.00%)
After-hours: Aug 12, 2026, 4:50 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
27.83
+0.21 (0.76%)
At close: Aug 12, 2026, 4:00 PM EDT
27.83
0.00 (0.00%)
After-hours: Aug 12, 2026, 4:50 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $425.5M significantly exceed its total debt $82.0K, ensuring strong financial flexibility
Total current assets $659.2M exceed Total current liabilities $73.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$39.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 9.03 | 6.05 | 10 | |
| Quick ratio | 9.03 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 103M | 14M | 46M | 23M | 7M |
| Gross Profit | 103M | 14M | 45M | 22M | 7M |
| Operating Income | -1M | -181M | -176M | -226M | -244M |
| Net Income | -23M | -177M | -242M | -204M | -260M |
| EBITDA | -1M | -181M | -176M | -225M | -244M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 2066.7 | 18.85 | 9.5 |
| Next quarter | N/A | 26.39 | 5.5 |
| Current year | 34.85 | -9.97 | 5.5 |
| Next year | 415.95 | 17.34 | 9.5 |
| Weighted average score | 7.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 21.74 | -32.39 | -29.99 | -28.23 | 3.3 |
| Y/Y | -80.66 | -269.35 | -246.66 | -4.06 | 1.0 |
| 3y average | 28.83 | -234.19 | -30.78 | -486.01 | 3.3 |
| 5y average | 416.9 | 1727.18 | -30.78 | 1252.32 | 7.8 |
| Weighted average score | 3.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |